Properties of Polyethylene Terephthalate (PET) after Thermo-Oxidative Aging.

The influence of the thermo-oxidative aging semi-crystalline polyethylene terephthalate process on the thermal and mechanical properties was analysed in the article. For this purpose, PET was aged at 140 °C for 21, 35 and 56 days. The research showed that as a result of aging, the amount of the crystalline phase increases by about 8%, which translates into the properties of the aged material. The glass transition and melt temperature of lamellar crystals formed during first and second crystallisation increase with aging. The mechanical properties of the material were analysed in the temperature range of 25 to 75 °C. The tests were showing an increase in Young's modulus and a decrease in elongation at the break as a result of aging. This phenomenon was particularly visible during tests at 75 °C and during the morphological observation of the fracture surface, where the fracture character of the material changes from ductile to brittle. In the case of the material aged for the longest time, the temperature has a negligible influence on the elongation at break.

Microstructure Evolution of 316L Steel Prepared with the Use of Additive and Conventional Methods and Subjected to Dynamic Loads: A Comparative Study.

The mechanical properties and microstructure evolution caused by dynamic loads of 316L stainless steel, fabricated using the Laser Engineered Net Shaping (LENS) technique and hot forging method were studied. Full-density samples, without cracks made of 316L stainless steel alloy powder by using the LENS technique, are characterized by an untypical bi-modal microstructure consisting of macro-grains, which form sub-grains with a similar crystallographic orientation. Wrought stainless steel 316L has an initial equiaxed and one-phase structure, which is formed by austenite grains. The electron backscattered diffraction (EBSD) technique was used to illustrate changes in the microstructure of SS316L after it was subjected to dynamic loads, and it was revealed that for both samples, the grain refinement increases as the deformation rate increases. However, in the case of SS316L samples made by LENS, the share of low-angle boundaries (sub-grains) decreases, and the share of high-angle boundaries (grains of austenite) increases. Dynamically deformed wrought SS316L is characterized by the reverse trend: a decrease in the share of high-angle boundaries and an increase in the share of low-angle boundaries. Moreover, additively manufactured SS316L is characterized by lower plastic flow stresses compared with hot-forged steel, which is caused by the finer microstructure of wrought samples relative to that of additive samples. In the case of additively manufactured 316L steel samples subjected to a dynamic load, plastic deformation occurs predominantly through dislocation slip, in contrast to the wrought samples, in which the dominant mechanism of deformation is twinning, which is favored by a high deformation speed and low stacking fault energy (SFE) for austenite.

High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction.

Chemerin is an adipokine modulating inflammatory response and affecting glucose and lipid metabolism. These disturbances are common in CKD. The aim of the study was: (a) to evaluate circulating chemerin level at different stages of CKD; (b) to measure subcutaneous adipose tissue chemerin gene expression; (c) to estimate the efficiency of renal replacement therapy in serum chemerin removal. 187 patients were included into the study: a) 58 patients with CKD; (b) 29 patients on hemodialysis; (c) 20 patients after kidney transplantation. 80 subjects constituted control group. Serum chemerin concentration was estimated by ELISA. The adipose tissue chemerin mRNA level was measured by RT-qPCR. The mean serum chemerin concentration in CKD patients was 70% higher than in the control group (122.9 ± 33.7 vs. 72.6 ± 20.7 ng/mL; p < 0.001) and it negatively correlated with eGFR (r = -0.71, p < 0.001). The equally high plasma chemerin level was found in HD patients and a HD session decreased it markedly (115.7 ± 17.6 vs. 101.5 ± 16.4 ng/mL; p < 0.001). Only successful kidney transplantation allowed it to get down to the values noted in controls (74.8 ± 16.0 vs. 72.6 ± 20.7 ng/mL; n.s.). The level of subcutaneous adipose tissue chemerin mRNA in CKD patients was not different than in patients of the control group. The study demonstrates that elevated serum chemerin concentration in CKD patients: (a) is related to kidney function, but not to increased chemerin production by subcutaneous adipose tissue, and (b) it can be efficiently corrected by hemodialysis treatment and normalized by kidney transplantation.

Elevated circulating PCSK-9 concentration in renal failure patients is corrected by renal replacement therapy.

BACKGROUND: A high level of circulating PCSK9 binds to the LDL receptor, reduces its cell's surface density and leads to hypercholesterolemia. The aim of this study was to examine the circulating PCSK9 level in patients with kidney disease. METHODS: Out of the patients treated in our Departments we selected: (a) 44 patients with CKD stage 3 and 4 (b) 29 patients with CKD stage 5 on maintenance hemodialysis treatment; and (c) 20 patients after successful renal transplantation. Thirty-four subjects, without CKD formed the control group. Serum biochemical parameters' concentrations were assayed by a certified laboratory. Serum PCSK9 concentration was estimated by a commercially available ELISA kit. RESULTS: The mean serum concentration of PCSK9 in patients with kidney disease was higher than in the control group (238.7 ± 64.5 vs. 536.7 ± 190.4; p < 0.001). A strong negative correlation between serum PCSK9 concentration and eGFR was found (r = -0.66; p < 0.001), as well as between serum concentrations of PCSK9 and total- (r = 0.482; p < 0.05) or LDL-cholesterol (r = 0.533; p < 0.05), but exclusively in patients not receiving statins. The elevated serum concentration of PCSK9 in patients before hemodialysis session declined afterwards, reaching the values observed in patients after kidney transplantation and in the control group. CONCLUSION: The circulating PCSK9 concentration is increased in patients with CKD; however, this is not accompanied by hypercholesterolemia. The positive correlations between PCSK9/TCh and PCSK9/LDL-Ch have been found only in patients not treated with statins. The elevated circulating PCSK9 level is corrected by maintenance hemodialysis treatment and normalized by a successful kidney transplantation.